EGFR mutation analysis and treatment outcomes with tyrosine kinase inhibitors in EGFR mutants: The Manchester Lung Cancer Group Experience.

R Peck, E Connolly, P Taylor, C Faivre-Finn, FH Blackhall, A Wallace, L Lee, N Bayman, P Burt, YJ Summers

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Number of pages1
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20 May 2012

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this